Skip to main content
See every side of every news story
Published • loading... • Updated

2 Cancer Drugs From Li Ka-Shing-Backed Sequencio Garner Global Attention

Summary by BizToc
Two cancer vaccines from Hong Kong-based Sequencio Therapeutics have been selected for presentation at a major US conference, as companies bet on therapies based on ribonucleic acid (RNA) to deliver breakthroughs in cancer treatment. Sequencio, a subsidiary of Li Ka-shing-backed CK Life Sciences,…

8 Articles

The Manila TimesThe Manila Times
+4 Reposted by 4 other sources
Lean Right

CK Life Sciences’ Sequencio Therapeutics to Present New Data from Lead Cancer Vaccine Programmes at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting

**media[1291128]**

·Manila, Philippines (the)
Read Full Article

HONG KONG SAR — Media OutReach Newswire — 4 November 2026 — Sequencio Therapeutics Company Limited (“Sequencio”), a subsidiary of CK Life Sciences Int'l., (Holdings) Inc. (“CK Life Sciences”), today...

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center, 50% of the sources lean Right
50% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The InfoStride broke the news on Wednesday, November 4, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal